Exact Sciences
EXAS
#1382
Rank
A$19.62 B
Marketcap
$106.24
Share price
2.34%
Change (1 day)
-8.55%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -A$0.24 B

According to Exact Sciences's latest financial reports the company's current earnings (TTM) are -A$0.24 B. In 2023 the company made an earning of -A$0.28 B an increase over its 2022 earnings that were of -A$0.93 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.24 B-15.93%
2023 -A$0.28 B-69.98%
2022 -A$0.93 B-25.55%
2021 -A$1.25 B1.68%
2020 -A$1.23 B271.17%
2019 -A$0.33 B58.99%
2018 -A$0.21 B20.89%
2017 -A$0.18 B-30.95%
2016 -A$0.25 B5.09%
2015 -A$0.24 B57.24%
2014 -A$0.16 B116.53%
2013 -A$69.44 M
2011 -A$43.24 M143.73%
2010 -A$17.74 M27.85%
2009 -A$13.88 M0.27%
2008 -A$13.84 M-20.95%
2007 -A$17.51 M-13.53%
2006 -A$20.25 M-10.07%
2005 -A$22.52 M-21.81%
2004 -A$28.8 M-33.44%
2003 -A$43.26 M-6.51%
2002 -A$46.27 M17.95%
2001 -A$39.23 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 B-0.95%๐Ÿ‡บ๐Ÿ‡ธ USA
A$98.81 M-142.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$82.18 M-64.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$52.45 M-77.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.12 B-4,458.48%๐Ÿ‡ซ๐Ÿ‡ท France